Galectin Therapeutics
GALT
#8251
Rank
C$0.21 B
Marketcap
$3.52
Share price
0.59%
Change (1 day)
26.88%
Change (1 year)

EPS for Galectin Therapeutics (GALT)

EPS in 2023 (TTM): -$0.89

According to Galectin Therapeutics's latest financial reports the company's current EPS (TTM) is -$0.91. In 2022 the company made an earnings per share (EPS) of -$0.90 a decrease over its 2021 EPS that were of -$0.72.

EPS history for Galectin Therapeutics from 2002 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$0.89-1.08%
2022-$0.9025%
2021-$0.7230%
2020-$0.55-6.98%
2019-$0.6013.16%
2018-$0.53-22.45%
2017-$0.68-35.53%
2016-$1.05-13.64%
2015-$1.2211.39%
2014-$1.10-39.69%
2013-$1.8281.94%
2012-$1.00-32.08%
2011-$1.477.07%
2010-$1.37-17.5%
2009-$1.66150%
2008-$0.67-68%
2007-$2.08127.27%
2006-$0.91-52.17%
2005-$1.91-20.69%
2004-$2.4152.63%
2003-$1.58-13.64%
2002-$1.83

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$17.77 1,842.42%๐Ÿ‡บ๐Ÿ‡ธ USA
-$0.26-71.21%๐Ÿ‡บ๐Ÿ‡ธ USA